AntiAging Atlanta

AntiAging Atlanta, located in Alpharetta, Georgia, operates under the medical direction of Dr. Randy Smith, providing hormone optimization and peptide therapy protocols designed to address age-related decline in metabolic function, body composition, and recovery capacity. The clinic serves patients throughout the Atlanta metropolitan area and offers hybrid consultation models that combine in-person evaluations with telehealth follow-up for residents of Georgia and Florida. Dr. Smith's practice focuses on evidence-based interventions that target the underlying mechanisms of aging rather than symptomatic management alone, with particular emphasis on growth hormone secretagogue therapy and comprehensive hormone panel interpretation.

The peptide therapy program at AntiAging Atlanta centers on three growth hormone-releasing peptides: CJC-1295, Ipamorelin, and Sermorelin. CJC-1295 is utilized for its extended half-life and ability to amplify growth hormone pulses without significantly elevating cortisol or prolactin levels, making it suitable for patients seeking sustained improvements in lean muscle retention and sleep architecture. Ipamorelin is prescribed both as monotherapy and in combination protocols for its selective ghrelin receptor activation, which stimulates growth hormone release while minimizing appetite disruption and blood sugar fluctuations. Sermorelin, a growth hormone-releasing hormone analog consisting of the first 29 amino acids of the native hormone, is employed for patients who respond well to physiologic stimulation of the pituitary gland. The clinic designs peptide protocols based on individual hormone testing, body composition analysis, and specific patient goals such as enhanced recovery from exercise, improved skin elasticity, or optimization of metabolic rate.

Dr. Randy Smith brings clinical experience in age management medicine to his patient consultations, conducting comprehensive intake evaluations that include detailed medical history review, current medication assessment, and discussion of lifestyle factors affecting hormone balance. Initial consultations at the Alpharetta clinic typically involve baseline laboratory work that measures IGF-1 levels, complete hormone panels including thyroid function, and metabolic markers to establish pre-treatment values. Dr. Smith's approach emphasizes patient education regarding the physiologic rationale for peptide selection, expected timelines for clinical effects, and the importance of adjunctive interventions such as resistance training and adequate protein intake to maximize peptide therapy outcomes. Follow-up protocols include periodic lab monitoring and dose adjustments based on symptomatic response and objective biomarker changes.

Patients beginning peptide therapy at AntiAging Atlanta can expect a structured onboarding process that includes injection technique training, detailed administration schedules, and clear communication regarding potential side effects such as injection site reactions or transient water retention. The clinic provides patients with pharmaceutical-grade peptides from certified compounding pharmacies, along with written protocols specifying reconstitution procedures, storage requirements, and dosing frequency. Most peptide regimens require subcutaneous injections administered five to six days per week, typically in the evening to align with natural growth hormone secretion patterns. The clinic schedules follow-up assessments at six to eight week intervals during the initial treatment phase to evaluate patient tolerance, adherence, and early response indicators such as changes in energy levels, sleep quality, and body composition measurements.

AntiAging Atlanta's hybrid care model allows Georgia and Florida residents to complete initial consultations in person at the Alpharetta office, with subsequent follow-ups conducted via telehealth platforms for patients who prefer remote monitoring. This approach provides continuity of care for patients with demanding schedules or those traveling between the two states, while maintaining the clinical oversight necessary for safe peptide therapy management. The clinic's telehealth infrastructure supports secure messaging for patient questions, electronic lab result review, and video consultations for dose adjustments or protocol modifications. Dr. Smith's practice maintains a patient-centered focus that prioritizes individualized treatment design over standardized protocols, recognizing that peptide therapy response varies based on age, baseline hormone status, and concurrent health conditions.